Arcus Development Group Aktie
Finanztrends
Deine Einschätzung
Was spricht für und gegen Arcus Development Group in den nächsten Jahren?
Pro
?
L*********** I********** f** d** n******* J****
?
U****************
?
W******* i* V********
Kontra
?
A****************
?
M****
?
M************
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Arcus Development Group im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Arcus Development Group | - | - | - | - | - | - | - |
| Nevada Sunrise Metals Corp. | -1,92 % | -8,93 % | -21,54 % | 131,82 % | 131,82 % | -80,38 % | -53,21 % |
| Orla Mining Ltd | 3,32 % | 4,89 % | 6,90 % | 108,41 % | 110,18 % | 208,86 % | 170,63 % |
| Trailbreaker Resources Ltd. | -8,70 % | -16,56 % | -19,23 % | -30,77 % | -25,88 % | 154,55 % | -14,86 % |
Kommentare
News
Arcus Biosciences President Sells $2 Million in Stock Under Trading Plan
Juan C. Jaen, the president of Arcus Biosciences (NYSE:RCUS), sold 96,859 shares in multiple open-market transactions on Tuesday and Wednesday, according to an SEC Form 4 filing.
The transaction
Arcus (RCUS) Q2 Revenue Jumps 310%
Arcus Biosciences (NYSE:RCUS), a clinical-stage biotech focused on cancer immunotherapies, reported its second-quarter 2025 earnings on August 6, 2025. GAAP revenue and earnings per share both